The Effect of Proprioceptive Neuromuscular Facilitation and Mirror Therapy on Range of Motion, Pain, Functionality, Kinesophobia and Quality of Life in Patients With Upper Extremity Burns

Purpose of the study; The aim of this study was to investigate the effect of two different exercise programs on joint patency, pain, functionality, kinesophobia and quality of life in upper extremity burn patients. Lütfi Kırdar Training and Research Hospital Burn and Wound Center and unilateral upper extremity burns will consist of individuals aged 18-65 years. 48 burn patients who volunteered to participate in the study will be included in the study. Demographic information of the cases will be recorded. Joint range of motion and pain will be evaluated with the Visual Analogue Scale (VAS) before and after the treatment program. Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire will be used to evaluate upper extremity functions. TAMPA Kinezophobia questionnaire will also be used for kinesiophobia. To evaluate the quality of life, Burn-Specific Health Scale developed for burn patients will be used.

Study Overview

• Status: Unknown
• Conditions: Burn; Arm
• Intervention / Treatment: Other: Effect of exercise

Detailed Description

Joint range of motion of the subjects will be measured with a goniometer. Pain will be evaluated with the Visual Analogue Scale (VAS). In order to evaluate the upper extremity functions, the validity and reliability of the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, conducted by Tülin Düger et al. The TAMPA Kinezophobia questionnaire, which has been validated and validated in 2011, will be used for kinesiophobia. The Burn-Specific Health Scale developed for burn patients will be used to evaluate the quality of life. The validity and reliability study of the questionnaire was conducted by Mehmet Adam et al.

• Study Type: Observational
• Enrollment (Anticipated): 48

Contacts and Locations

Study Locations

• Turkey
  • Istanbul, Turkey, 34865
    • Recruiting
    • Wound and Burn Center
    • Contact: Mine Seyyah, Msc; Phone Number: 0905333566908; Email: mine-fzt@hotmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Acute Burn Patients

Description

Inclusion Criteria: -18-65 years of age, -the unilateral upper extremity burn, -the understanding of the given information, the application of mirror therapy and the ability to accurately express the level of pain that prevents cognitive, affective and verbal communication There is no problem and no visual impairment, - Turkish reading and writing, - Paralysis, plaster, etc. that will prevent movement in the extremity opposite the burned extremity. to be cognitive enough to understand the surveys,

- Agreeing to participate voluntarily in the study -

Exclusion Criteria:

• T.C. Ministry of Health Kartal Lütfi Kırdar Training and Research Hospital Burn and Wound Center treated patients between the ages of 0-18,
• Burn patients who refused to participate in the study, - Patients with bilateral upper extremity burns

Study Plan

How is the study designed?

Number of groups / cohorts

3

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
proprioceptive neuromuscular facilitation; PNF will be applied to randomly selected patients.	Other: Effect of exercise; Once the data are available, we hope to have information about which of the exercise practices included in the rehabilitation program of acute upper extremity burn patients is more effective.
Mirror therapy; Mirror therapy will be applied to randomly selected patients.	Other: Effect of exercise; Once the data are available, we hope to have information about which of the exercise practices included in the rehabilitation program of acute upper extremity burn patients is more effective.
Standart therapy; Standard treatment will be applied to randomly selected patients.	Other: Effect of exercise; Once the data are available, we hope to have information about which of the exercise practices included in the rehabilitation program of acute upper extremity burn patients is more effective.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Demographic information	Demographic information of the cases will be recorded.Age, cause of burn, burn zone, burn percentage will be recorded.	10 minutes
Joint range of motion	The goniometer will measure the range of motion.	15 minutes
Pain assesment	Pain will be assessed by visual pain scale.	5 minutes
Functional assesment	Shoulder-Arm Function Questionnaire will be used to evaluate upper extremity functions.	15 minutes
Fear of Motion	The Tampa Kinesophobia Questionnaire will be used to assess fear of movement.	10 minutes
Quality of Life Assesment	A scale specific to burn patients will be used to evaluate the quality of life.(Burn Specific Health Scale)	15 minutes

Collaborators and Investigators

• Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital
• Investigators: Study Chair: Mine Seyyah, DrLutfiKirdar

Study record dates

Study Major Dates

• Study Start (ACTUAL): May 1, 2019
• Primary Completion (ANTICIPATED): September 20, 2019
• Study Completion (ANTICIPATED): December 15, 2019

Study Registration Dates

• First Submitted: June 18, 2019
• First Submitted That Met QC Criteria: June 24, 2019
• First Posted (ACTUAL): June 25, 2019

Study Record Updates

• Last Update Posted (ACTUAL): June 25, 2019
• Last Update Submitted That Met QC Criteria: June 24, 2019
• Last Verified: June 1, 2019

More Information

Terms related to this study

• Keywords: burn, physiotherapy
• Additional Relevant MeSH Terms: Wounds and Injuries; Burns
• Other Study ID Numbers: Kartal Wound and Burn Center

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No